Corteva (CTVA) Stock Forecast & Price Target

Q: What analysts cover Corteva?

Corteva has been rated by research analysts at Barclays , BNP Paribas Exane , CICC Research , Citigroup , Deutsche Bank Aktiengesellschaft , Jefferies Financial Group , Mizuho , Morgan Stanley , Oppenheimer , Rothschild & Co Redburn , Royal Bank Of Canada , UBS Group , Weiss Ratings , Wells Fargo & Company , and Zacks Research in the past 90 days.

$86.74 +2.29 (+2.71%)

Closing price 03:59 PM Eastern

Extended Trading

$86.67 -0.07 (-0.08%)

As of 06:04 PM Eastern

Compare

Corteva - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
8

Buy
14

Based on 22 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 8 have given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for CTVA.

Consensus Price Target

$88.95
2.55% Upside

According to the 22 analysts' twelve-month price targets for Corteva, the average price target is $88.95. The highest price target for CTVA is $100.00, while the lowest price target for CTVA is $77.00. The average price target represents a forecasted upside of 2.55% from the current price of $86.74.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTVA Analyst Ratings Over Time

Type	Current Forecast 7/16/25 to 7/16/26	1 Month Ago 6/16/25 to 6/16/26	3 Months Ago 4/17/25 to 4/17/26	1 Year Ago 7/16/24 to 7/16/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)
Hold	8 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$88.95	$88.81	$84.52	$77.38
Forecasted Upside	2.55% Upside	15.58% Upside	5.08% Upside	6.00% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Consumer Staples Companies	Broader Market
Consensus Rating Score	2.68	2.09	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	4.56% Upside	124.07% Upside	13.28% Upside
News Sentiment Rating	Positive News See Recent CTVA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/14/2026	Mizuho 4 of 5 stars	John Roberts 4 of 5 stars	Boost Target	Outperform	$96.00 ➝ $97.00	+12.87%
7/13/2026	Zacks Research Not Rated		Upgrade	Hold ➝ Strong-Buy
6/11/2026	Barclays 3 of 5 stars	Benjamin Theurer 1 of 5 stars	Boost Target	Overweight	$84.00 ➝ $91.00	+22.00%
6/9/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$90.00 ➝ $86.00	+13.09%
5/28/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Andrews Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$84.00 ➝ $95.00	+18.91%
5/13/2026	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$80.00 ➝ $93.00	+12.31%
5/11/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+22.65%
5/7/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C) ➝ Hold (C+)
5/7/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$95.00 ➝ $97.00	+22.58%
5/7/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$83.00 ➝ $85.00	+7.41%
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
5/7/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$95.00 ➝ $97.00	+19.27%
5/6/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$74.00 ➝ $77.00	-5.32%
4/29/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$80.00 ➝ $90.00	+13.41%
4/22/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Owen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$86.00 ➝ $89.00	+10.55%
4/21/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$85.00 ➝ $90.00	+11.99%
4/14/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$88.00 ➝ $96.00	+15.02%
3/31/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Selesky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$80.00 ➝ $91.00	+9.01%
3/26/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$68.00 ➝ $78.00	-6.38%
2/5/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$81.00 ➝ $86.00	+17.97%
2/5/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$75.00 ➝ $77.00	+2.56%
1/8/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$80.00 ➝ $82.00	+16.46%
10/3/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aleksey Yefremov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Sector Weight
9/15/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$86.00	+22.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:20 PM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 14, 2026. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

The company reported strong earnings per share (EPS) of $1.50 for the latest quarter, significantly exceeding analysts' expectations, indicating robust financial performance.
Corteva, Inc. has shown a year-over-year revenue growth of 11.0%, reflecting its ability to expand and capture market share in the agriculture sector.
The current stock price is around $96, which has been positively influenced by recent upgrades from multiple analysts, suggesting strong market confidence.
The firm has a solid dividend payout ratio of 42.35%, providing a reliable income stream for investors through its quarterly dividends.
Analysts forecast an EPS of 3.72 for the current fiscal year, indicating potential for continued profitability and growth.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

Despite recent growth, the company's net margin of 6.50% may indicate challenges in maintaining profitability compared to industry peers.
Market volatility and economic uncertainties could impact agricultural demand, potentially affecting Corteva's revenue and growth prospects.
With a dividend yield of only 0.8%, the returns from dividends may not be attractive enough for income-focused investors.
Analysts have mixed ratings, with some holding a "neutral" stance, which may suggest uncertainty about the company's future performance.
As a relatively new independent entity, Corteva, Inc. may still face integration and operational challenges following its separation from DowDuPont.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $88.95, with a high forecast of $100.00 and a low forecast of $77.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last twelve months. There are currently 8 hold ratings, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted upside of 2.55% based on their 12-month stock forecasts.

Over the previous 90 days, Corteva's stock had 2 upgrades by analysts.

Corteva has been rated by research analysts at Barclays, BNP Paribas Exane, CICC Research, Citigroup, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, Mizuho, Morgan Stanley, Oppenheimer, Rothschild & Co Redburn, Royal Bank Of Canada, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Corteva Recommendations

This page (NYSE:CTVA) was last updated on 7/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target